These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32208041)

  • 21. T1G3 bladder cancer--the case for TUR and BCG.
    Miller K
    Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bladder carcinoma].
    Lycklama à Nijeholt AA
    Ned Tijdschr Geneeskd; 1992 Jun; 136(23):1097-102. PubMed ID: 1603169
    [No Abstract]   [Full Text] [Related]  

  • 23. Initial results of retrospective study: preoperative transurethral excision plus chemotherapy and radiation therapy and trial of bladder preservation.
    Gamal El-Deen HS
    J Egypt Natl Canc Inst; 2007 Jun; 19(2):133-46. PubMed ID: 19034344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive bladder carcinoma: progress in basic research, surgical and medical therapy.
    Ratliff TL; Rao GS; Ritchey JK
    Eur Urol; 1998; 33 Suppl 4():15. PubMed ID: 9615201
    [No Abstract]   [Full Text] [Related]  

  • 25. Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer?
    Kuczyk M; Turkeri L; Hammerer P; Ravery V;
    Eur Urol; 2003 Jul; 44(1):57-64. PubMed ID: 12814676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T1G3: What to do?
    Mandressi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
    [No Abstract]   [Full Text] [Related]  

  • 27. Editorial Comment to Cancer death from non-muscle invasive bladder cancer: Report of the Japanese Urological Association of data from the 1999-2001 registry in Japan.
    Koga F
    Int J Urol; 2010 Nov; 17(11):913. PubMed ID: 20969638
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of bladder cancer in the elderly].
    Fröhner M; Rübben H
    Urologe A; 2015 Apr; 54(4):510-5. PubMed ID: 25794588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
    Freiha F; Reese J; Torti FM
    J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 31. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
    Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
    J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
    [No Abstract]   [Full Text] [Related]  

  • 32. [Usefulness of radiotherapy in the treatment of infiltrating bladder cancer].
    Escudero Barrilero A
    Arch Esp Urol; 1990; 43 Suppl 2():165-84. PubMed ID: 1710884
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant Chemotherapy Before Bladder-Sparing Chemoradiotherapy in Patients With Nonmetastatic Muscle-Invasive Bladder Cancer.
    Jiang DM; Jiang H; Chung PWM; Zlotta AR; Fleshner NE; Bristow RG; Berlin A; Kulkarni GS; Alimohamed NS; Lo G; Sridhar SS
    Clin Genitourin Cancer; 2019 Feb; 17(1):38-45. PubMed ID: 30686350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of intravesical therapy on progression of superficial transitional cell carcinoma of the bladder. A metaanalytic comparison of chemotherapy versus bacilli Calmette-Guerin immunotherapy.
    Montie JE
    J Urol; 2005 Nov; 174(5):1783-4. PubMed ID: 16217285
    [No Abstract]   [Full Text] [Related]  

  • 36. Evolving concepts in muscle-invasive bladder cancer.
    Black PC; Kassouf W
    World J Urol; 2016 Jan; 34(1):1-2. PubMed ID: 26743671
    [No Abstract]   [Full Text] [Related]  

  • 37. [Infiltrating transitional carcinoma of the bladder (4). Our approach to stage pT2 and critique of other risk factors. Multifactorial analysis].
    Escudero Barrilero A; Perales L; Romero J; Rodríguez Luna JM; Vallejo J; Rivas JA
    Actas Urol Esp; 1991; 15(5):411-20. PubMed ID: 1807119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current status of the conservative treatment of urinary bladder for invasive bladder cancer].
    Ueda K; Sakagami H; Kato F; Mogami T; Ohtaguro K
    Hinyokika Kiyo; 1991 Dec; 37(12):1597-9. PubMed ID: 1785380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neo-adjuvant and adjuvant chemotherapy of bladder cancer: Is there a role?
    Sternberg CN
    Ann Oncol; 2002; 13 Suppl 4():273-9. PubMed ID: 12401701
    [No Abstract]   [Full Text] [Related]  

  • 40. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
    Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
    J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.